Loading viewer...
report
Format: PDF report
This document is Ligand Pharmaceuticals' Q3 2017 quarterly report, detailing financial performance and compliance with SEC regulations.
presentation
report
Thanachart Securities
report
Chevron
report
AL HAMRA TOWER
report
Marquis Macadamias